Scientific Symposium

KSF hosts an annual Scientific Symposium for the research community to foster collaborations, encourage knowledge-sharing, and enable professionals to share their latest findings related to Kabuki syndrome.

A summary of the virtual meeting held on October 26, 2023 is now available. The 2023 Symposium featured four themes and was facilitated by KSF’s Chief Scientific Officer, Dr. Bruce Bloom, and Director of Research, Dr. Clara Tang. Register below to be notified of our next event!

Sign Up for Updates

More Opportunities to Connect

Monthly Kabuki Syndrome Lab Meetings Commence April 2024

We are hosting a series of lab-update style meetings to enhance knowledge exchange, collaboration, and interaction within the Kabuki syndrome research community. All researchers and clinicians with an interest in Kabuki syndrome are invited to this meeting; research groups will present updates on a rotating basis. The rotating schedule of presentations will include members and representatives from the labs and clinics of our Medical & Scientific Advisory Board.

If you would like to join this interactive meeting, please complete the form below. You can also indicate if you or your group would like to present at an upcoming meeting. This collaboration underscores the foundation’s role in facilitating a cooperative approach among the world’s leading researchers and clinicians in discovering treatments for Kabuki syndrome. We welcome your innovative ideas and commitment to knowledge-sharing in pursuit of treatments. Questions can be directed to Dr. Clara Tang, Director of Research: clara@kabukisyndromefoundation.org

Join us!

Register for Monthly Lab Meetings

Symposium Summary Available

We hosted over 60 clinicians, researchers and investigators at the 2023 KSF Scientific Symposium on Thursday, October 26th, 2023.

This event marked an opportunity to interact with some of the Kabuki syndrome community’s best minds, including members of our distinguished Medical Advisory Board. Attendees dove deeper into the latest Kabuki syndrome research, forged valuable collaborations, and gained enlightening insights into their own research and practice.

The symposium featured 10-minute oral virtual presentations on the following four themes, followed by Q&A:

  • Genetics and epigenetics: explore the genetic and epigenetic mechanisms underlying Kabuki syndrome, including functions of KMT2D and KDM6A and the molecular pathways that are affected.
  • Kabuki syndrome phenotypes: the latest insights on the pathways and mechanisms underlying neurological, immune and metabolic features of Kabuki syndrome.
  • Therapeutic opportunities: potential pharmacological interventions and the latest advances in treatment strategies for Kabuki syndrome.
  • Diagnosis and clinical trial readiness: recent research on diagnostic methods, biomarkers and outcome measures development.

Read the summary below and reach out to KSF’s Director of Research, Dr. Clara Tang, with any questions.